Henry Schein Completes Spin-Off Of Global Animal Health Business

Go back to Henry Schein Completes Spin-Off Of Global Animal Health Business

Henry Schein (HSIC) PT Lowered to $59 at UBS

February 12, 2019 9:12 AM EST

UBS analyst Kevin Caliendo lowered the price target on Henry Schein (NASDAQ: HSIC) to $59.00 (from $73.00) while maintaining a Sell rating.

... More